Diabetes Care, Vol 23, Issue 8 1113-1118, Copyright © 2000 by American Diabetes Association

ARTICLES

Plasma glucose and prediction of microvascular disease and mortality: evaluation of 1997 American Diabetes Association and 1999 World Health Organization criteria for diagnosis of diabetes

MM Gabir, RL Hanson, D Dabelea, G Imperatore, J Roumain, PH Bennett and WD Knowler
National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona 85014, USA.

OBJECTIVE: The 1997 American Diabetes Association (ADA) and 1999 World Health Organization (WHO) criteria for diabetes and hyperglycemia were evaluated and compared with respect to prediction of microvascular and macrovascular disease and mortality RESEARCH DESIGN AND METHODS: The prevalence of retinopathy and nephropathy at baseline and during the subsequent 10 years and mortality rates were examined in relation to baseline fasting plasma glucose (FPG) and 2-h postload plasma glucose (2-h PG) among 5,023 Pima Indian adults and in relation to the cut points defined by the ADA and WHO criteria. RESULTS: The frequencies of retinopathy and nephropathy were directly related to baseline FPG and 2-h PG with approximate thresholds near or below the current diagnostic criteria for diabetes (FPG > or =7.0 and 2-h PG > or = 11.1 mmol/l). The rates of retinopathy were 4.7% in impaired fasting glucose (IFG) and 20.9% in diabetes by ADA criteria; 1.6% for impaired glucose tolerance (IGT) and 19.7% for diabetes by 1985 WHO criteria; and 1.2% for IGT and 19.2% for diabetes by the 1999 WHO criteria. Mortality rates from cardiovascular-renal-related diseases were higher in diabetic individuals (FPG > or =7.0 or 2-h PG > 11.1 mmol/l) than in those with normal FPG and 2-h PG but were not elevated in those with IFG or IGT. CONCLUSIONS: Retinopathy and nephropathy were directly related to higher FPG or 2-h PG. FPG, which identifies those at high risk of microvascular disease and mortality, can be used to predict these outcomes and to diagnose diabetes when oral glucose tolerance testing is not practical.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				N. H. Kim, M. E. Pavkov, H. C. Looker, R. G. Nelson, P. H. Bennett, R. L. Hanson, J. M. Curtis, M. L. Sievers, and W. C. Knowler Plasma Glucose Regulation and Mortality in Pima Indians Diabetes Care, March 1, 2008; 31(3): 488 - 492. [Abstract] [Full Text] [PDF]

				M. C. Monti, J. T. Lonsdale, C. Montomoli, R. Montross, E. Schlag, and D. A. Greenberg Familial Risk Factors for Microvascular Complications and Differential Male-Female Risk in a Large Cohort of American Families with Type 1 Diabetes J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4650 - 4655. [Abstract] [Full Text] [PDF]

				J.-S. Wu, Y.-C. Yang, T.-S. Lin, Y.-H. Huang, J.-J. Chen, F.-H. Lu, C.-H. Wu, and C.-J. Chang Epidemiological Evidence of Altered Cardiac Autonomic Function in Subjects with Impaired Glucose Tolerance But Not Isolated Impaired Fasting Glucose J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3885 - 3889. [Abstract] [Full Text] [PDF]

				M. A. Abdul-Ghani, K. Williams, R. DeFronzo, and M. Stern Risk of Progression to Type 2 Diabetes Based on Relationship Between Postload Plasma Glucose and Fasting Plasma Glucose Diabetes Care, July 1, 2006; 29(7): 1613 - 1618. [Abstract] [Full Text] [PDF]

				M. A. Abdul-Ghani, C. P. Jenkinson, D. K. Richardson, D. Tripathy, and R. A. DeFronzo Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the veterans administration genetic epidemiology study. Diabetes, May 1, 2006; 55(5): 1430 - 1435. [Abstract] [Full Text] [PDF]

				J. de Jager, J. M. Dekker, A. Kooy, P. J. Kostense, G. Nijpels, R. J. Heine, L. M. Bouter, and C. D.A. Stehouwer Endothelial Dysfunction and Low-Grade Inflammation Explain Much of the Excess Cardiovascular Mortality in Individuals With Type 2 Diabetes: The Hoorn Study Arterioscler. Thromb. Vasc. Biol., May 1, 2006; 26(5): 1086 - 1093. [Abstract] [Full Text] [PDF]

				E. J. Brunner, M. J. Shipley, D. R. Witte, J. H. Fuller, and M. G. Marmot Relation Between Blood Glucose and Coronary Mortality Over 33 Years in the Whitehall Study Diabetes Care, January 1, 2006; 29(1): 26 - 31. [Abstract] [Full Text] [PDF]

				M. Berger, D. Monks, H. Schmidt, V. Krane, C. Wanner, U. Walter, and T. H. Lindner Are Glucokinase Mutations Associated with Low Triglycerides? Clin. Chem., April 1, 2005; 51(4): 791 - 793. [Full Text] [PDF]

				D. Tanne, N. Koren-Morag, and U. Goldbourt Fasting Plasma Glucose and Risk of Incident Ischemic Stroke or Transient Ischemic Attacks: A Prospective Cohort Study Stroke, October 1, 2004; 35(10): 2351 - 2355. [Abstract] [Full Text] [PDF]

				Expert Committee on the Diagnosis and Classificati Follow-up Report on the Diagnosis of Diabetes Mellitus Clin. Diabetes, April 1, 2004; 22(2): 71 - 79. [Full Text] [PDF]

				Follow-up Report on the Diagnosis of Diabetes Mellitus Diabetes Spectr, January 1, 2004; 17(1): 51 - 59. [Full Text] [PDF]

				J. R. Singleton, A. G. Smith, J. W. Russell, and E. L. Feldman Microvascular Complications of Impaired Glucose Tolerance Diabetes, December 1, 2003; 52(12): 2867 - 2873. [Abstract] [Full Text] [PDF]

				The Expert Committee on the Diagnosis and Classifi Follow-up Report on the Diagnosis of Diabetes Mellitus Diabetes Care, November 1, 2003; 26(11): 3160 - 3167. [Full Text] [PDF]

				A. M.W. Spijkerman, J. M. Dekker, G. Nijpels, M. C. Adriaanse, P. J. Kostense, D. Ruwaard, C. D.A. Stehouwer, L. M. Bouter, and R. J. Heine Microvascular Complications at Time of Diagnosis of Type 2 Diabetes Are Similar Among Diabetic Patients Detected by Targeted Screening and Patients Newly Diagnosed in General Practice: The Hoorn Screening Study Diabetes Care, September 1, 2003; 26(9): 2604 - 2608. [Abstract] [Full Text] [PDF]

				D. R. Jesudason, K. Dunstan, D. Leong, and G. A. Wittert Macrovascular Risk and Diagnostic Criteria for Type 2 Diabetes: Implications for the use of FPG and HbA1c for cost-effective screening Diabetes Care, February 1, 2003; 26(2): 485 - 490. [Abstract] [Full Text] [PDF]

				M. Scavini, C. A. Stidley, V. O. Shah, A. S. Narva, F. Tentori, D. S. Kessler, A. Bobelu, C. P. Albert, J. Bobelu, E. Jamon, et al. Prevalence of Diabetes Is Higher Among Female than Male Zuni Indians Diabetes Care, January 1, 2003; 26(1): 55 - 60. [Abstract] [Full Text] [PDF]

				J. Tuomilehto Point: A Glucose Tolerance Test Is Important for Clinical Practice Diabetes Care, October 1, 2002; 25(10): 1880 - 1882. [Full Text] [PDF]

				H. A. van Leiden, J. M. Dekker, A. C. Moll, G. Nijpels, R. J. Heine, L. M. Bouter, C. D.A. Stehouwer, and B. C.P. Polak Blood Pressure, Lipids, and Obesity Are Associated With Retinopathy: The Hoorn Study Diabetes Care, August 1, 2002; 25(8): 1320 - 1325. [Abstract] [Full Text] [PDF]

				H. C. Gerstein Fasting Versus Postload Glucose Levels: Why the controversy? Diabetes Care, November 1, 2001; 24(11): 1855 - 1857. [Full Text] [PDF]

				S. H. Saydah, M. Miret, J. Sung, C. Varas, D. Gause, and F. L. Brancati Postchallenge Hyperglycemia and Mortality in a National Sample of U.S. Adults Diabetes Care, August 1, 2001; 24(8): 1397 - 1402. [Abstract] [Full Text] [PDF]

				J. Krakoff, R. L. Hanson, S. Kobes, and W. C. Knowler Comparison of the Effect of Plasma Glucose Concentrations on Microvascular Disease Between Pima Indian Youths and Adults Diabetes Care, June 1, 2001; 24(6): 1023 - 1028. [Abstract] [Full Text]